-
公开(公告)号:US09776970B2
公开(公告)日:2017-10-03
申请号:US15120226
申请日:2015-02-20
申请人: Apotex Inc.
发明人: Padiyath Mohammed Akbarali , Venkata Ramana Kintali , Heggadde Nanjunda Bhatta Shreenivasa Murthy , Girisha Meenkere , Somanath Bhupal Venkata , Raja Ramesh Manda , Vishal Amrutlal Sodha , Abbulu Kante
IPC分类号: C07D401/12 , A61K31/496 , C07D215/54 , A61K31/4706 , A61K9/14
CPC分类号: C07D215/54 , A61K9/146 , A61K31/4706
摘要: The present subject matter relates to solvates and the amorphous form of bosutinib; the solvates namely being a propylene glycol solvate and an acetonitrile solvate. Also provided are processes for preparing the propylene glycol solvate, the amorphous form and the crystalline acetonitrile solvate of bosutinib; as well as compositions comprising said forms. Bosutinib is a 3-quinolinecarbonitrile kinase inhibitor and is indicated for the treatment of adult patients with chronic, accelerated, or blast phase Ph+ chronic myelogenous leukemia (CMS) with resistance or intolerance to prior therapy.
-
公开(公告)号:US20170057923A1
公开(公告)日:2017-03-02
申请号:US15120226
申请日:2015-02-20
申请人: Apotex Inc.
发明人: Padiyath Mohammed Akbarali , Venkata Ramana Kintali , Heggadde Nanjunda Bhatta Shreenivasa Murthy , Girisha Meenkere , Somanath Bhupal Venkata , Raja Ramesh Manda , Vishal Amrutlal Sodha , Abbulu Kante
IPC分类号: C07D215/54
CPC分类号: C07D215/54 , A61K9/146 , A61K31/4706
摘要: The present subject matter relates to solvates and the amorphous form of bosutinib; the solvates namely being a propylene glycol solvate and an acetonitrile solvate. Also provided are processes for preparing the propylene glycol solvate, the amorphous form and the crystalline acetonitrile solvate of bosutinib; as well as compositions comprising said forms. Bosutinib is a 3-quinolinecarbonitrile kinase inhibitor and is indicated for the treatment of adult patients with chronic, accelerated, or blast phase Ph+ chronic myelogenous leukemia (CMS) with resistance or intolerance to prior therapy.
摘要翻译: 本主题涉及溶剂化物和博丝替尼的无定形形式; 溶剂化物即丙二醇溶剂合物和乙腈溶剂合物。 还提供了制备波生菌素的丙二醇溶剂化物,无定形形式和结晶乙腈溶剂合物的方法; 以及包含所述形式的组合物。 Bosutinib是一种3-喹啉腈激酶抑制剂,用于治疗慢性,加速或爆发期Ph +慢性粒细胞白血病(CMS)的成年患者,其具有耐药性或不耐受以前的治疗。
-